2006 - Janet Pettit

Congratulations to Janet Pettit, MSN, RNC, NP

Winner of the 2006 Suzanne LaVere Herbst Award for excellence in vascular access

Janet Pettit is the recipient of the Suzanne LaVere Herbst Award for Excellence in Vascular Access Practice, sponsored by Genentech, Inc., for 2006. The award was presented at the AVA Conference in Indianapolis, IN, in September 2006. The following profile was provided.

Janet’s background includes over 30 years of neonatal intensive care experience as a clinical nurse, manager, outreach educator, clinical nurse specialist and nurse practitioner.  She is currently employed in the 45-bed neonatal intensive care unit (NICU) at Doctors Medical Center in Modesto, CA, as a neonatal nurse practitioner and clinical nurse specialist.  An interest in vascular access devices has led to multiple publications, clinical research, and national and international speaking engagements. 

Ms. Pettit’s unique expertise makes her a sought-after consultant to the vascular access device industry. Through work with multiple NICUs across the United States and Canada, she has gathered a vast knowledge of care practices for infants with vascular access devices, particularly peripherally inserted central catheters (PICCs). 

Ms. Pettit is the co-author of the PICC Guidelines produced by the National Association of Neonatal Nurses and serves as a reviewer for the Infusion Nurses Society Infusion Nursing Standards of Practice and AVA’s Journal of the Association for Vascular Access.  She has served professional organizations in a variety of roles, including the Board of Directors for the National Association of Neonatal Nurses and the Association for Vascular Access, where she has chaired the Education Committee.

On the basis of her outstanding performance as a nurse, her skill as a gifted educator and speaker, her contributions as a researcher, and her commitment and dedication to AVA, Janet Pettit earned the 2006 Suzanne LaVere Herbst Award for Excellence in Vascular Access Practice, sponsored by Genentech, Inc.